Mackenzie Financial Corp acquired a new position in shares of AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 7,992 shares of the insurance provider's stock, valued at approximately $412,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Nuveen Asset Management LLC increased its stake in AMERISAFE by 92.1% during the 4th quarter. Nuveen Asset Management LLC now owns 161,815 shares of the insurance provider's stock worth $8,340,000 after acquiring an additional 77,582 shares during the period. Franklin Resources Inc. bought a new stake in AMERISAFE during the fourth quarter worth about $359,000. Ameriprise Financial Inc. lifted its position in AMERISAFE by 7.8% during the fourth quarter. Ameriprise Financial Inc. now owns 102,843 shares of the insurance provider's stock worth $5,301,000 after purchasing an additional 7,399 shares during the period. Deutsche Bank AG lifted its position in AMERISAFE by 52.0% during the fourth quarter. Deutsche Bank AG now owns 18,610 shares of the insurance provider's stock worth $959,000 after purchasing an additional 6,366 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in AMERISAFE by 3.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 661,795 shares of the insurance provider's stock worth $34,109,000 after purchasing an additional 21,799 shares during the period. Institutional investors own 97.41% of the company's stock.
Analyst Ratings Changes
Separately, JMP Securities reaffirmed a "market outperform" rating and set a $65.00 price objective on shares of AMERISAFE in a research report on Wednesday, April 30th.
View Our Latest Report on AMERISAFE
AMERISAFE Price Performance
AMSF traded up $0.30 on Friday, hitting $45.84. 185,103 shares of the stock were exchanged, compared to its average volume of 107,999. AMERISAFE, Inc. has a 12 month low of $41.97 and a 12 month high of $60.24. The business has a 50-day moving average of $47.99 and a two-hundred day moving average of $50.67. The firm has a market capitalization of $873.25 million, a price-to-earnings ratio of 14.33 and a beta of 0.42.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last posted its earnings results on Tuesday, April 29th. The insurance provider reported $0.60 EPS for the quarter, topping analysts' consensus estimates of $0.59 by $0.01. The firm had revenue of $83.78 million during the quarter, compared to analysts' expectations of $76.66 million. AMERISAFE had a net margin of 19.49% and a return on equity of 16.50%. Equities research analysts expect that AMERISAFE, Inc. will post 2.45 earnings per share for the current fiscal year.
AMERISAFE Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 13th will be issued a $0.39 dividend. The ex-dividend date is Friday, June 13th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 3.40%. AMERISAFE's dividend payout ratio (DPR) is currently 62.90%.
AMERISAFE Company Profile
(
Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
See Also

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.